APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy
May 20, 2024 08:00 ET
|
APRINOIA Therapeutics, Inc.
CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics (“Aprinoia” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics and precision...
[Latest] Global Carbonated Beverages Market Size/Share Worth USD 771.3 Billion by 2033 at a 5.60% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 17, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, May 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Carbonated Beverages Market Size, Trends and Insights By Product Type (Cola...
Post-consumer Recycled Plastics Market Analysis Report 2024, By Source (Bottles, Non-bottle Rigid), By Type (PP, PS, PE, PVC, PET) and Region
May 16, 2024 10:40 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Post-consumer Recycled Plastics Market Size, Share & Trends Analysis Report By Source (Bottles, Non-bottle Rigid), By Type (PP, PS, PE, PVC, PET),...
[Latest] Global Sports and Energy Drinks Market Size/Share Worth USD 150.22 Billion by 2033 at a 7.48% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 14, 2024 05:30 ET
|
Custom Market Insights
Austin, TX, USA, May 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Sports and Energy Drinks Market Size, Trends and Insights By Product Type (Sports...
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
April 25, 2024 10:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
April 23, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
April 19, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a...
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
April 18, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
CARBIOS公司在2024年香港国际创科展（InnoEX）之际荣获“非常法国、非凡创新”（So French So Innovative）奖，该奖项旨在表彰法国在亚太地区的卓越创新贡献
April 16, 2024 12:30 ET
|
Carbios
CARBIOS公司在2024年香港国际创科展（InnoEX）之际荣获“非常法国、非凡创新”（So French So Innovative）奖，该奖项旨在表彰法国在亚太地区的卓越创新贡献 ...
CARBIOS remporte le prix « So French So Innovative » à l'occasion d’InnoEX 2024, Hong Kong, qui récompense l’innovation française dans la région Asie-Pacifique
April 16, 2024 12:30 ET
|
Carbios
CARBIOS remporte le prix « So French So Innovative » à l'occasion d’InnoEX 2024, Hong Kong, qui récompense l’innovation française dans la région Asie-Pacifique Clermont-Ferrand (France), le...